kt 5823 has been researched along with gw 1929 in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (gw 1929) | Trials (gw 1929) | Recent Studies (post-2010) (gw 1929) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 72 | 0 | 41 |
| Protein | Taxonomy | kt 5823 (IC50) | gw 1929 (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 4 | |
| Thromboxane-A synthase | Homo sapiens (human) | 2.953 | |
| Delta-type opioid receptor | Homo sapiens (human) | 3.209 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Lai, N; Lu, W; Ran, P; Wang, J; Xu, L; Yang, K; Zhang, Y; Zhong, N | 1 |
1 other study(ies) available for kt 5823 and gw 1929
| Article | Year |
|---|---|
Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARĪ³ axis.
Topics: Animals; Benzamides; Benzophenones; Carbazoles; Cell Movement; Cell Proliferation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation; Hypoxia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphodiesterase 5 Inhibitors; Piperazines; PPAR gamma; Protein Kinase Inhibitors; Pulmonary Artery; Purines; Pyridines; Rats; Rats, Wistar; Signal Transduction; Sildenafil Citrate; Sulfones; TRPC Cation Channels; Tyrosine | 2013 |